Home › Funds › FIDELIS CAPITAL PARTNERS, LLC › ABBV

FIDELIS CAPITAL PARTNERS, LLC position in ABBV

ABBVIE INC · Health Care

FIDELIS CAPITAL PARTNERS, LLC reported holding 39,748 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$10.4M, representing 0.58% of its reported portfolio and ranking #37 among its reported holdings. FIDELIS CAPITAL PARTNERS, LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)39.75K sh
Reported value held$10.40M
Portfolio Weight0.58%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How FIDELIS CAPITAL PARTNERS, LLC's ABBV position evolved

FIDELIS CAPITAL PARTNERS, LLC first disclosed a stake in ABBV in Q3 2023 at 13,557 shares (US$2.0M). The position peaked in Q3 2026 at 39,748 shares, worth US$10.4M. Across 13 filings, FIDELIS CAPITAL PARTNERS, LLC increased the stake 10 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 39,748 shares valued at US$10.4M — an increase of 1,062 shares quarter over quarter.. Notable position changes include a 28% increase in Q1 2024 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 13.56K $2.02M New
Q4 2023 16.16K $2.50M Add
Q1 2024 20.62K $3.75M Add
Q2 2024 22.97K $4.31M Add
Q3 2024 24.75K $4.65M Add
Q4 2024 26.96K $5.13M Add
Q1 2025 28.52K $5.31M Add
Q2 2025 28.37K $5.57M Reduce
Q3 2025 32.33K $7.48M Add
Q4 2025 34.12K $7.80M Add
Q1 2026 33.74K $7.34M Reduce
Q2 2026 38.69K $9.73M Add
Q3 2026 39.75K $10.40M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has FIDELIS CAPITAL PARTNERS, LLC held ABBV?

FIDELIS CAPITAL PARTNERS, LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is FIDELIS CAPITAL PARTNERS, LLC's current position in ABBV?

As of Q3 2026, FIDELIS CAPITAL PARTNERS, LLC holds 39.75K shares of ABBV (ABBVIE INC), valued at $10.40M, representing 0.58% of its reported portfolio and ranking #37.

Has FIDELIS CAPITAL PARTNERS, LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), FIDELIS CAPITAL PARTNERS, LLC increased its position in ABBV. The position peaked in Q3 2026 at 39.75K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.